Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Giovanna A. Zampierollo"'
Autor:
Elizabeth Liu, Jennifer E. Ho, Javier Díez, Begoña López, Emily S. Lau, Amy Sarma, Thomas J. Wang, Samantha M. Paniagua, Giovanna A. Zampierollo
Publikováno v:
JACC: Basic to Translational Science
Visual Abstract
Highlights • Gal-3 is a beta-galactoside–binding lectin that regulates inflammation and fibrosis and is highly predictive of heart failure events and mortality. • In a randomized placebo-controlled trial of MCP, Gal-3 inhib
Highlights • Gal-3 is a beta-galactoside–binding lectin that regulates inflammation and fibrosis and is highly predictive of heart failure events and mortality. • In a randomized placebo-controlled trial of MCP, Gal-3 inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d751a3dfc1f77fc0cd729f2b0572e2e
http://europepmc.org/articles/PMC7838053
http://europepmc.org/articles/PMC7838053
Autor:
Giovanna A. Zampierollo, Rajeev Malhotra, Cole S. Bailey, Jennifer E. Ho, Gregory D. Lewis, Aaron S. Eisman, Paul P. Pappagianopoulos, Matthew Nayor, Emily K. Zern, Kathryn M. Hardin, Luke Wooster, Petr Jarolim, Thomas F Cunningham
Publikováno v:
Circulation
Background: Heart failure with preserved ejection fraction (HFpEF) is common, yet there is currently no consensus on how to define HFpEF according to various society and clinical trial criteria. How clinical and hemodynamic profiles of patients vary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61b42fe8a787f26510107906ff510c93
https://europepmc.org/articles/PMC6684250/
https://europepmc.org/articles/PMC6684250/
